title: Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetry.
abstract: Electronic portal imaging devices (EPIDs) are increasingly used for portal dosimetry applications. In our department, EPIDs are clinically used for two-dimensional (2D) transit dosimetry. Predicted and measured portal dose images are compared to detect dose delivery errors caused for instance by setup errors or organ motion. The aim of this work is to develop a model to predict dose-volume histogram (DVH) changes due to setup errors during breast cancer treatment using 2D transit dosimetry. First, correlations between DVH parameter changes and 2D gamma parameters are investigated for different simulated setup errors, which are described by a binomial logistic regression model. The model calculates the probability that a DVH parameter changes more than a specific tolerance level and uses several gamma evaluation parameters for the planning target volume (PTV) projection in the EPID plane as input. Second, the predictive model is applied to clinically measured portal images. Predicted DVH parameter changes are compared to calculated DVH parameter changes using the measured setup error resulting from a dosimetric registration procedure. Statistical accuracy is investigated by using receiver operating characteristic (ROC) curves and values for the area under the curve (AUC), sensitivity, specificity, positive and negative predictive values. Changes in the mean PTV dose larger than 5%, and changes in V90 and V95 larger than 10% are accurately predicted based on a set of 2D gamma parameters. Most pronounced changes in the three DVH parameters are found for setup errors in the lateral-medial direction. AUC, sensitivity, specificity, and negative predictive values were between 85% and 100% while the positive predictive values were lower but still higher than 54%. Clinical predictive value is decreased due to the occurrence of patient rotations or breast deformations during treatment, but the overall reliability of the predictive model remains high. Based on our predictive model, 2D transit dosimetry measurements can now directly be translated in clinically more relevant DVH parameter changes for the PTV during conventional breast treatment. In this way, the possibility to design decision protocols based on extracted DVH changes is created instead of undertaking elaborate actions such as repeated treatment planning or 3D dose reconstruction for a large group of patients.
authors.affiliation: Department of Radiation Oncology (MAASTRO), GROW University Medical Center Maastricht, 6229 ET Maastricht, The Netherlands. bas.nijsten@maastro.nl
authors.forename: S M J J G
authors.initials: SM
authors.lastname: Nijsten
authors.forename: W J C
authors.initials: WJ
authors.lastname: van Elmpt
authors.forename: B J
authors.initials: BJ
authors.lastname: Mijnheer
authors.forename: A W H
authors.initials: AW
authors.lastname: Minken
authors.forename: L C G G
authors.initials: LC
authors.lastname: Persoon
authors.forename: P
authors.initials: P
authors.lastname: Lambin
authors.forename: A L A J
authors.initials: AL
authors.lastname: Dekker
mesh_terms: D000465:Algorithms; D016477:Artifacts; D001822:Body Burden; D001943:Breast Neoplasms / Q000532:radiotherapy*; D003198:Computer Simulation; D006801:Humans; D008954:Models, Biological; D011835:Radiation Protection / Q000379:methods*; D011874:Radiometry / Q000379:methods*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D012062:Relative Biological Effectiveness; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity